JD Supra October 27, 2021
McDermott Will & Emery

The US Department of Justice (DOJ) and US Department of Health and Human Services, Office of Inspector General (HHS-OIG) are increasingly relying on sophisticated data analytics tools to identify and investigate fraud schemes, particularly in the healthcare sector. DOJ’s announcement of four new False Claims Act settlements and cases involving similar fraudulent billing schemes further demonstrates the effectiveness and importance of DOJ and HHS-OIG’s data analytics programs. Healthcare companies should take steps to prepare for these data-driven enforcement actions and incorporate data analytics into their own compliance and audit programs.

IN DEPTH

The US Department of Justice (DOJ), US Department of Health and Human Services, Office...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Analytics, Govt Agencies, HHS, OIG, Provider, Technology
Bluesight Announces Acquisition of Protenus to Advance Healthcare Compliance and Risk Mitigation
How Tampa General Hospital’s Partnership with Palantir Is Shortening Its Innovation Timelines
MultiPlan rebrands amid price-fixing allegations
Inside 2 systems' pharmacy investment strategies for 2025
AI's Next Big Disruption: How 2025 Will Democratize Embedded Analytics

Share This Article